Difference between revisions of "Shi L, et al. Vitr. Cell Dev. Biol. Anim. (2015) cited as Ref 168 in DOI: 10.1038/s41392-020-0110-5 (Q9431)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: DOI Identifier (P138): 10.1007/s11626-015-9931-x, #quickstatements; #temporary_batch_1590000649558)
(‎Created claim: Fourth Author string (P152): You Y, #quickstatements; #temporary_batch_1590155310798)
 
(5 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2015
Timestamp+2015-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2015 / rank
 +
Normal rank
Property / Published In Name String
 +
Vitr. Cell Dev. Biol. Anim.
Property / Published In Name String: Vitr. Cell Dev. Biol. Anim. / rank
 +
Normal rank
Property / Volume
 +
51
Property / Volume: 51 / rank
 +
Normal rank
Property / title
 +
PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/beta-catenin signaling pathway (English)
Property / title: PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/beta-catenin signaling pathway (English) / rank
 +
Normal rank
Property / Page(s)
 +
1047-1055
Property / Page(s): 1047-1055 / rank
 +
Normal rank
Property / Fourth Author string
 +
You Y
Property / Fourth Author string: You Y / rank
 +
Normal rank

Latest revision as of 13:49, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Shi L, et al. Vitr. Cell Dev. Biol. Anim. (2015) cited as Ref 168 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Shi L
    0 references
    Fei X
    0 references
    Wang Z
    0 references
    2015
    0 references
    Vitr. Cell Dev. Biol. Anim.
    0 references
    51
    0 references
    PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/beta-catenin signaling pathway (English)
    0 references
    1047-1055
    0 references
    You Y
    0 references